Mast cell accumulation and cytokine expression in the tight skin mouse model of scleroderma

Experimental Dermatology

Volumn 14, Issue 4, 2005, Pages 295-302

  Wang, Hong Wei ^a,b   Tedla, Nicodemus ^a   Hunt, John E ^a   Wakefield, Denis ^a   McNeil, H Patrick ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

IL 15; Mast cell; Skin graft; TGF ; Tight skin

Indexed keywords

INTERLEUKIN 15; MESSENGER RNA; STEM CELL FACTOR; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DENSITY; CELL DIFFERENTIATION; CELL HYPERPLASIA; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; MAST CELL; MOUSE; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; RIBONUCLEASE PROTECTION ASSAY; SCLERODERMA; SKIN TRANSPLANTATION;

ANIMALS; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; COLLAGEN; CYTOKINES; DISEASE MODELS, ANIMAL; FIBROSIS; HETEROZYGOTE; IMMUNOHISTOCHEMISTRY; MAST CELLS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RIBONUCLEASES; RNA, MESSENGER; SCLERODERMA, SYSTEMIC; SKIN; SKIN TRANSPLANTATION; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 16844375906     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0906-6705.2005.00315.x     Document Type: Article

References (51)

1. Green M C, Sweet H O, Bunker L E. Tight-skin, a new mutation of the mouse causing excessive growth of connective tissue and skeleton. Am J Pathol 1976: 82: 493-512.
2. Siracusa L D, McGrath R, Ma Q et al. A tandem duplication within the fibrillin 1 gene is associated with the mouse tight skin mutation. Genome Res 1996: 6: 300-313.
3. Saito S, Nishimura H, Phelps R G et al. Induction of skin fibrosis in mice expressing a mutated fibrillin-1 gene. Mol Med 2000: 6: 825-836.
4. Bocchieri M H, Henriksen P D, Kasturi K N, Muryoi T, Bona C A, Jimenez S A. Evidence for autoimmunity in the tight skin mouse model of systemic sclerosis. Arthritis Rheum 1991: 34: 599-605.
5. Muryoi T, Kasturi K N, Kafina M J et al. Self reactive repertoire of tight skin mouse: immunochemical and molecular characterization of anti-topoisomerase I autoantibodies. Autoimmunity 1991: 9: 109-117.
6. Wallace V A, Kondo S, Kono T et al. A role for CD4+ T cells in the pathogenesis of skin fibrosis in tight skin mice. Eur J Immunol 1994: 24: 1463-1466.
7. Saito E, Fujimoto M, Hasegawa M et al. CD19-dependent B lymphocyte signaling thresholds influence skin fibrosis and autoimmunity in the tight-skin mouse. J Clin Invest 2002: 109: 1453-1462.
8. Oble D A, Teh H S. Tight skin mouse subcutaneous hypertrophy can occur in the absence of αβ T cell receptor-bearing lymphocytes. J Rheumatol 2001: 28: 1852-1855.
9. Siracusa L D, McGrath R, Fisher J K, Jimenez S A. The mouse tight skin (Tsk) phenotype is not dependent on the presence of mature T and B lymphocytes. Mamm Genome 1998: 9: 907-909.
10. Cairns J A, Walls A F. Mast cell tryptase stimulates the synthesis of type I collagen in human lung fibroblasts. J Clin Invest 1997: 99: 1313-1321.
11. Gruber B L, Kew R R, Jelaska A et al. Human mast cells activate fibroblasts - tryptase is a fibrogenic factor stimulating collagen messenger ribonucleic acid synthesis and fibroblast chemotaxis. J Immunol 1997: 158: 2310-2317.
12. Gruber B L, Marchese M J, Suzuki K et al. Synovial procollagenase activation by human mast cell tryptase dependence upon matrix metalloproteinase 3 activation. J Clin Invest 1989: 84: 1657-1662.
13. Johnson J L, Jackson C L, Angelini G D, George S J. Activation of matrix-degrading metalloproteinases by mast cell proteases in atherosclerotic plaques. Arterioscler Thromb Vasc Biol 1998: 18: 1707-1715.
14. Lindstedt K A, Wang Y, Shiota N et al. Activation of paracrine TGF-β1 signaling upon stimulation and degranulation of rat serosal mast cells: a novel function for chymase. FASEB J 2001: 15: 1377-1388.
15. Li C Y, Baek J Y. Mastocytosis and fibrosis: role of cytokines. Int Arch Allergy Immunol 2002: 127: 123-126.
16. Walker M, Harley R, Maize J, DeLustro F, LeRoy E C. Mast cells and their degranulation in the Tsk mouse model of scleroderma. Proc Soc Exp Biol Med 1985: 180: 323-328.
17. Everett E T, Pablos J L, Harley R A, LeRoy E C, Norris J S. The role of mast cells in the development of skin fibrosis in tight-skin mutant mice. Comp Biochem Physiol A Physiol 1995: 110: 159-165.
18. Walker M, Harley R, LeRoy E C. Ketotifen prevents skin fibrosis in the tight skin mouse. J Rheumatol 1990: 17: 57-59.
19. McNeil H P, Austen K F. Biology of the mast cell. In: Frank M M, Austen K F, Claman H N, Unanue E R, eds. Samter's Immunologic Diseases, Vol. 1. Boston: Little, Brown and Company, 1995: 185-204.
20. Akimoto S, Ishikawa O, Igarashi Y, Kurosawa M, Miyachi Y. Dermal mast cells in scleroderma - their skin density, tryptase/chymase phenotypes and degranulation. Br J Dermatol 1998: 138: 399-406.
21. T cells in the skin and evidence of mast cell activation. Arthritis Rheum 1992: 35: 933-939.
22. Junqueira L C, Bignolas G, Brentani R R. Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J 1979: 11: 447-455.
23. McNeil H P, Frenkel D P, Austen K F, Friend D S, Stevens R L. Translation and granule localization of mouse mast cell protease-5. Immunodetection with specific anti-peptide Ig. J Immunol 1992: 149: 2466-2472.
24. Ghildyal N, Friend D S, Nicodemus C F, Austen K F, Stevens R L. Reversible expression of mouse mast cell protease 2 mRNA and protein in cultured mast cells exposed to IL-10. J Immunol 1993: 151: 3206-3214.
25. Hunt J E, Chen J, McNeil H P et al. Induction of IL-15 and a novel mouse mast cell phenotype in mice infected with Helicobacter felis (Abstract). FASEB J 1999: 13: A291.
26. Wang H W, Tedla N, Lloyd A R, Wakefield D, McNeil H P. Mast cell activation and migration to lymph nodes during induction of an immune response in mice. J Clin Invest 1998: 102: 1617-1626.
27. Meininger C J, Yano H, Rottapel R, Bernstein A, Zsebo K M, Zetter B R. The c-kit receptor ligand functions as a mast cell chemoattractant. Blood 1992: 79: 958-963.
28. Nilsson G, Butterfield J H, Nilsson K, Siegbahn A. Stem cell factor is a chemotactic factor for human mast cells. J Immunol 1994: 153: 3717-3723.
29. Gruber B L, Marchese M J, Kew R R. Transforming growth factor β1 mediates mast cell chemotaxis. J Immunol 1994: 152: 5860-5867.
30. Tagaya Y, Burton J D, Miyamoto Y, Waldmann T A. Identification of a novel receptor/signal transduction pathway for IL-15/T in mast cells. EMBO J 1996: 15: 4928-4939.
31. de Boer W I, van Schadewijk A, Sont J K et al. Transforming growth factor β1 and recruitment of macrophages and mast cells in airways in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998: 158: 1951-1957.
32. Olsson N, Piek E, ten Dijke P, Nilsson G. Human mast cell migration in response to members of the transforming growth factor-β family. J Leukoc Biol 2000: 67: 350-356.
33. Masuda A, Matsuguchi T, Yamaki K, Hayakawa T, Yoshikai Y. Interleukin-15 prevents mouse mast cell apoptosis through STAT6-mediated Bcl-xL expression. J Biol Chem 2001: 276: 26107-26113.
34. Saito S, Nishimura H, Brumeanu T D et al. Characterization of mutated protein encoded by partially duplicated fibrillin-1 gene in tight skin (TSK) mice. Mol Immunol 1999: 36: 169-176.
35. Lemaire R, Farina G, Kissin E et al. Mutant fibrillin 1 from tight skin mice increases extracellular matrix incorporation of microfibril-associated glycoprotein 2 and type I collagen. Arthritis Rheum 2004: 50: 915-926.
36. Phelps R G, Daian C, Shibata S, Fleischmajer R, Bona C A. Induction of skin fibrosis and autoantibodies by infusion of immunocompetent cells from tight skin mice into C57BL/6 Pa/Pa mice. J Autoimmun 1993: 6: 701-718.
37. Pablos J L, Everett E T, Harley R, LeRoy E C, Norris J S. Transforming growth factor-β1 and collagen gene expression during postnatal skin development and fibrosis in the tight-skin mouse. Lab Invest 1995: 72: 670-678.
38. Olsson N, Piek E, Sundstrom M, ten Dijke P, Nilsson G. Transforming growth factor-β mediated mast cell migration depends on mitogen-activated protein kinase activity. Cell Signal 2001: 13: 483-490.
39. Mason G I, Hamburger J, Matthews J B. Mast cells, extracellular matrix components, TGF β isoforms and TGFβ receptor expression in labial salivary glands in systemic sclerosis. Ann Rheum Dis 2000: 59: 183-189.
40. Yamamoto T, Takagawa S, Katayama I, Nishioka K. Anti-sclerotic effect of transforming growth factor-beta antibody in a mouse model of bleomycin-induced scleroderma. Clin Immunol 1999: 92: 6-13.
41. Austen K F, Boyce J A. Mast cell lineage development and phenotypic regulation. Leuk Res 2001: 25: 511-518.
42. Kaneko Y, Takenawa J, Yoshida O et al. Adhesion of mouse mast cells to fibroblasts: adverse effects of steel (Sl) mutation. J Cell Physiol 1991: 147: 224-230.
43. Mekori Y A, Oh C K, Metcalfe D D. The role of c-Kit and its ligand, stem cell factor, in mast cell apoptosis. Int Arch Allergy Immunol 1995: 107: 136-138.
44. Newlands G F, Miller H R, MacKellar A, Galli S J. Stem cell factor contributes to intestinal mucosal mast cell hyperplasia in rats infected with Nippostrongylus brasiliensis or Trichinella spiralis, but anti-stem cell factor treatment decreases parasite egg production during N brasiliensis infection. Blood 1995: 86: 1968-1976.
45. Jackson NE, Wang H-W, Teola N et al. IL-15 induces mast cell migration via a pertussis toxin-sensitive receptor (submitted).
46. Hebda P A, Collins M A, Tharp M D. Mast cell and myofibroblast in wound healing. Dermatol Clin 1993: 11: 685-696.
47. Persinger M A, Lepage P, Simard J P, Parker G H. Mast cell numbers in incisional wounds in rat skin as a function of distance, time and treatment. Br J Dermatol 1983: 108: 179-187.
48. Trautmann A, Toksoy A, Engelhardt E, Brocker E B, Gillitzer R. Mast cell involvement in normal human skin wound healing: expression of monocyte chemoattractant protem-1 is correlated with recruitment of mast cells which synthesize interleukin-4 in vivo. aJ Pathol 2000: 190: 100-106.
49. Gijbels M J J, HogenEsch H, Bruijnzeel P L B, Elliott G R, Zurcher C. Maintenance of donor phenotype after full-thickness skin transplantation from mice with chronic proliferative dermatitis (cpdm/cpdm) to C57BL/Ka and nude mice and vice versa. J Invest Dermatol 1995: 105: 769-773.
50. Christofidou-Solomidou M, Longley B J, Whitaker-Menezes D et al. Human skin/SCID mouse chimeras as an in vivo model for human cutaneous mast cell hyperplasia. J Invest Dermatol 1997: 109: 102-107.
51. Kakizoe E, Shiota N, Tanabe Y, Shimoura K, Kobayashi Y, Okunishi H. Isoform-selective upregulation of mast cell chymase in the development of skin fibrosis in scleroderma model mice. J Invest Dermatol 2001: 116: 118-123.